Eco R1 Capital, LLC Crinetics Pharmaceuticals, Inc. Transaction History
Eco R1 Capital, LLC
- $2.83 Billion
- Q2 2024
A detailed history of Eco R1 Capital, LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 4,155,375 shares of CRNX stock, worth $249 Million. This represents 6.58% of its overall portfolio holdings.
Number of Shares
4,155,375
Previous 4,155,375
-0.0%
Holding current value
$249 Million
Previous $195 Million
4.32%
% of portfolio
6.58%
Previous 5.55%
Shares
9 transactions
Others Institutions Holding CRNX
# of Institutions
247Shares Held
78.5MCall Options Held
268KPut Options Held
197K-
Black Rock Inc. New York, NY6.23MShares$373 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.11MShares$366 Million2.95% of portfolio
-
Wellington Management Group LLP Boston, MA4.62MShares$276 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.51MShares$270 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.41MShares$264 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $3.21B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...